Galatea Bio
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- $25M
Investors
- 8
About Galatea Bio
Galatea Bio, Inc.Founded in 2020, Galatea Bio, Inc. operates in Miami Lakes, US, focusing on providing genomic services. The founder’s history includes previous entrepreneurial ventures, although specific details are not provided.Galatea Bio's primary offerings center around clinical testing and biobanking services that harness human genetic diversity to address pressing challenges in biomedicine. Their core products include next-generation sequencing molecular diagnostics and a comprehensive biobank, which are both CLIA-CMS certified and CAP-accredited, ensuring high-quality results for clients. The company provides a testing catalog that enables physicians to investigate genetic variations and biological pathways that are critical for patient care. Galatea Bio collaborates with pharmaceutical companies, academic institutions, and health systems globally, focusing on large-scale population sequencing programs.Galatea Bio generates revenue primarily through partnerships and collaborations with pharmaceutical and life sciences organizations, as well as through academic institutions that utilize their biobanking and sequencing services. Business transactions typically occur through contractual agreements where clients engage Galatea Bio to conduct genetic testing and analysis, enabling them to access a wealth of genomic data for research and development purposes. The company’s flagship offering, StrataRisk™, provides polygenic risk scores for common diseases, which further supports its revenue model by catering to healthcare providers interested in precision medicine.In March 2025, Galatea Bio, Inc., AME Cloud Ventures, CEI Ventures Management, Digitalis Ventures, Founder Collective, F-Prime Capital, HBM Genomics, and Helios Investment Partners. The company is also planning to introduce new products aimed at improving healthcare outcomes and is targeting expansion into additional markets in Latin America by 2026.
Who invested in Galatea Bio
8 investors across 1 round
See all investors in Galatea Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 27, 2025
Amount
$25M
Investors
Questions about Galatea Bio
Who invested in Galatea Bio?
Galatea Bio has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Galatea Bio raised?
Galatea Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Galatea Bio last raise money?
Galatea Bio's most recent round on record is a Series A, in Mar 2025.
What does Galatea Bio do?
Galatea Bio is a biotechnology company.
Where is Galatea Bio headquartered?
Galatea Bio is headquartered in Miami Lakes, US.
Which VCs invest in companies like Galatea Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Galatea Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Galatea Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.